Barry Heavey, Head of Life Sciences at IDA Ireland, Ireland’s inward investment promotion agency, discusses IDA’s focus on acting as a catalyst for B2B collaboration in converging industries like connective health solutions and innovative drug delivery devices, their focus on advanced manufacturing, and his mission to make IDA Ireland the best investment promotion agency in the world.
Can you provide an overview of IDA Ireland’s mandate in the life sciences?
Fundamentally, we want IDA Ireland to be the catalyst to support the growth of strong sectors such as biopharma, medtech and tech and then position Ireland as a global collaborative hub for convergence between these strategic sectors.
